Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 114.73MCore Assets
VS
Market
Sector
Industry
History
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information
Ticker
URGNCompany Name
UROGEN PHARMA LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQUROGEN PHARMA LTD - Core Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
URGN - Core Assets Historical data
| Date | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
|---|---|---|---|---|
| 6/30/2025 | $ 208.72M | $ 93.99M | $ 114.73M | $ 0 |
| 3/31/2025 | $ 247.62M | $ 105.11M | $ 142.51M | $ 0 |
| 12/31/2024 | $ 285.71M | $ 173.06M | $ 112.65M | $ 0 |
| 9/30/2024 | $ 301.94M | $ 125.99M | $ 175.95M | $ 0 |
| 6/30/2024 | $ 281.85M | $ 220.8M | $ 61.05M | $ 0 |
| 3/31/2024 | $ 200.57M | $ 132.26M | $ 68.31M | $ 0 |
| 12/31/2023 | $ 178.31M | $ 95.82M | $ 82.49M | $ 0 |
| 9/30/2023 | $ 193.63M | $ 120.12M | $ 73.51M | $ 0 |
| 6/30/2023 | $ 95.36M | $ 20.94M | $ 74.42M | $ 0 |
| 3/31/2023 | $ 112.95M | $ 37.35M | $ 75.6M | $ 0 |
Key Performance Insights, Last 5 Years
- UROGEN PHARMA LTD's latest trailing twelve months (TTM) Core Assets stands at $ 114.1M.
- Over the past 5 years, UROGEN PHARMA LTD's average Core Assets has been $ 88.16M.
- The median Core Assets for UROGEN PHARMA LTD during this period was $ 76.82M
- UROGEN PHARMA LTD reached its highest Core Assets over the past 5 years at $ 175.95M.
- The lowest Core Assets recorded by UROGEN PHARMA LTD in the same timeframe $ 55.7M
UROGEN PHARMA LTD's Core Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Core Assets Benchmarks
Similar metrics to Intangibles:
- Tangible Assets - [Calculation] A tangible asset is an asset that has physical substance. Typical examples may include [Inventory], equipment or machinery an property. It is calculated by subtracting intangibles & goodwill [Intangibles] from total [Assets].
- Goodwill & Intangibles to Assets Ratio - [Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Goodwill and Intangibles - [Balance Sheet] Goodwill and Intangible Assets are a component of [Assets] representing nonphysical assets like goodwill, patents, trademarks, and copyrights; net of accumulated amortization and impairment charges.
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Core Assets
[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].Assets - Intangibles - CashnEq
(=) Core Assets Core Assets for UROGEN PHARMA LTD is calculated as follows: Assets [ $ 139.89M ] - Intangibles [ $ 0 ] - CashnEq [ $ 25.79M ]
(=) Core Assets [ $ 114.1M ] URGN - Core Assets, Last 5 years
$ 55.7M
Minimum
Mar 31, 2021
$ 175.95M
Maximum
Sep 30, 2024
$ 88.16M
Average
$ 76.82M
Median
Core Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.36M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | $ 0 |
| max | $ 4.36B |
| average | $ 798.36M |
| median | $ 287.51M |
| std | $ 1.05B |